Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
308%
upside
7 price targets
|
0
%
|
|
|
|
207%
upside
7 price targets
|
0
%
|
|
|
|
184%
upside
8 price targets
|
0
%
|
|
|
4
Viking Therapeutics
VKTX
$4.13B
|
164%
upside
4 price targets
|
0
%
|
|
|
143%
upside
5 price targets
|
0
%
|
|
|
|
132%
upside
8 price targets
|
0
%
|
|
|
|
123%
upside
9 price targets
|
0
%
|
|
|
|
109%
upside
3 price targets
|
0
%
|
|
|
|
101%
upside
8 price targets
|
0
%
|
|
|
|
98%
upside
11 price targets
|
0
%
|
|
|
11
Dyne Therapeutics
DYN
$3.27B
|
95%
upside
8 price targets
|
0
%
|
|
|
95%
upside
6 price targets
|
0
%
|
|
|
|
95%
upside
3 price targets
|
0
%
|
|
|
|
93%
upside
10 price targets
|
0
%
|
|
|
|
92%
upside
4 price targets
|
0
%
|
|
|
|
89%
upside
7 price targets
|
0
%
|
|
|
|
88%
upside
4 price targets
|
0
%
|
|
|
|
86%
upside
9 price targets
|
0
%
|
|
|
|
85%
upside
4 price targets
|
0
%
|
|
|
|
84%
upside
3 price targets
|
0
%
|
|
|
|
84%
upside
9 price targets
|
0
%
|
|
|
|
81%
upside
7 price targets
|
0
%
|
|
|
|
78%
upside
4 price targets
|
0
%
|
|
|
|
77%
upside
3 price targets
|
0
%
|
|
|
|
77%
upside
7 price targets
|
0
%
|
|